A recurrent neural network uncovers a non-canonical human GRHL1 DNA-binding site
A convolutional recurrent neural network found 46 GRHL1 ChIP-seq sites missed by a conventional position-weight matrix, including sequences lacking the previously considered obligatory CNNG motif. Isothermal titration calorimetry confirmed GRHL1 binding to a selected non-canonical sequence lacking that core motif; nucleotide mutagenesis experiments also showed that model scores tracked measured affinity across tested variants.
Technology: Convolutional recurrent neural network trained on GRHL1 HT-SELEX binding data
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Isothermal titration calorimetry confirmed GRHL1 binding to a selected non-canonical sequence lacking that core motif; nucleotide mutagenesis experiments also showed that model scores tracked measured affinity across tested variants.
- Still unknown: Only one of the 46 predicted non-canonical sites was directly validated by ITC in this study; 46 is a model-nominated set, not 46 experimentally confirmed bindings. Biochemical affinity was tested with the isolated GRHL1 DNA-binding domain and synthetic DNA, not in vivo transcriptional effects for the novel site.
- AI role: The CNN/RNN learned GRHL1 sequence-binding patterns from HT-SELEX and scored human-cell ChIP-seq peaks. It identified 46 sites not detected by FIMO/PWM; one selected high-scoring non-canonical site was experimentally confirmed by ITC, and predicted variant affinity changes were compared with ITC results.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10696883/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 31 of works of the same type, year and subfield (OpenAlex work metrics, 2 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.